293 related articles for article (PubMed ID: 20695846)
1. The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.
Ovens MJ; Manoharan C; Wilson MC; Murray CM; Halestrap AP
Biochem J; 2010 Oct; 431(2):217-25. PubMed ID: 20695846
[TBL] [Abstract][Full Text] [Related]
2. AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.
Ovens MJ; Davies AJ; Wilson MC; Murray CM; Halestrap AP
Biochem J; 2010 Jan; 425(3):523-30. PubMed ID: 19929853
[TBL] [Abstract][Full Text] [Related]
3. Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity.
Nancolas B; Sessions RB; Halestrap AP
Biochem J; 2015 Feb; 466(1):177-88. PubMed ID: 25437897
[TBL] [Abstract][Full Text] [Related]
4. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).
Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP
J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240
[TBL] [Abstract][Full Text] [Related]
5. Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.
Guan X; Rodriguez-Cruz V; Morris ME
AAPS J; 2019 Jan; 21(2):13. PubMed ID: 30617815
[TBL] [Abstract][Full Text] [Related]
6. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model.
Guan X; Bryniarski MA; Morris ME
AAPS J; 2018 Nov; 21(1):3. PubMed ID: 30397860
[TBL] [Abstract][Full Text] [Related]
8. The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity.
Manoharan C; Wilson MC; Sessions RB; Halestrap AP
Mol Membr Biol; 2006; 23(6):486-98. PubMed ID: 17127621
[TBL] [Abstract][Full Text] [Related]
9. Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle.
Wilson MC; Meredith D; Bunnun C; Sessions RB; Halestrap AP
J Biol Chem; 2009 Jul; 284(30):20011-21. PubMed ID: 19473976
[TBL] [Abstract][Full Text] [Related]
10. Glucose-dependent growth arrest of leukemia cells by MCT1 inhibition: Feeding Warburg's sweet tooth and blocking acid export as an anticancer strategy.
Pivovarova AI; MacGregor GG
Biomed Pharmacother; 2018 Feb; 98():173-179. PubMed ID: 29253765
[TBL] [Abstract][Full Text] [Related]
11. The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface.
Wilson MC; Kraus M; Marzban H; Sarna JR; Wang Y; Hawkes R; Halestrap AP; Beesley PW
PLoS One; 2013; 8(11):e78654. PubMed ID: 24260123
[TBL] [Abstract][Full Text] [Related]
12. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
[TBL] [Abstract][Full Text] [Related]
13. Basigin interacts with both MCT1 and MCT2 in murine spermatozoa.
Mannowetz N; Wandernoth P; Wennemuth G
J Cell Physiol; 2012 May; 227(5):2154-62. PubMed ID: 21792931
[TBL] [Abstract][Full Text] [Related]
14. Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70.
Forero-Quintero LS; Ames S; Schneider HP; Thyssen A; Boone CD; Andring JT; McKenna R; Casey JR; Deitmer JW; Becker HM
J Biol Chem; 2019 Jan; 294(2):593-607. PubMed ID: 30446621
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates.
Wang N; Jiang X; Zhang S; Zhu A; Yuan Y; Xu H; Lei J; Yan C
Cell; 2021 Jan; 184(2):370-383.e13. PubMed ID: 33333023
[TBL] [Abstract][Full Text] [Related]
16. The monocarboxylate transporter family--Structure and functional characterization.
Halestrap AP
IUBMB Life; 2012 Jan; 64(1):1-9. PubMed ID: 22131303
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
Bröer S; Bröer A; Schneider HP; Stegen C; Halestrap AP; Deitmer JW
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):529-35. PubMed ID: 10417314
[TBL] [Abstract][Full Text] [Related]
18. Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.
Hanson DJ; Nakamura S; Amachi R; Hiasa M; Oda A; Tsuji D; Itoh K; Harada T; Horikawa K; Teramachi J; Miki H; Matsumoto T; Abe M
Oncotarget; 2015 Oct; 6(32):33568-86. PubMed ID: 26384349
[TBL] [Abstract][Full Text] [Related]
19. The SLC16 gene family - structure, role and regulation in health and disease.
Halestrap AP
Mol Aspects Med; 2013; 34(2-3):337-49. PubMed ID: 23506875
[TBL] [Abstract][Full Text] [Related]
20.
Rodriguez-Cruz V; Morris ME
J Pharmacol Exp Ther; 2021 Jul; 378(1):42-50. PubMed ID: 33963018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
